Novavax (NVAX) Announces $388M Funding from CEPI for COVID-19 Vaccine

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. RMR
6. GOOG
7. SPY
8. ANGO
9. LULU
10. PEP

Go back to Novavax (NVAX) Announces $388M Funding from CEPI for COVID-19 Vaccine

Novavax (NVAX) PT Raised to $38 at Ladenburg Thalmann

May 12, 2020 8:19 AM EDT

Ladenburg Thalmann analyst Michael Higgins raised the price target on Novavax (NASDAQ: NVAX) to $38.00 (from $28.00) while maintaining a Buy rating.

The analyst commented, "Last night, Novavax announced its 1Q20 results, presenting a $0.58 loss per share, better than our estimate of -$0.77... More

Novavax (NVAX) Tops Q1 EPS by 20c, Revenues Beat

May 11, 2020 5:04 PM EDT

Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.58), $0.20 better than the analyst estimate of ($0.78). Revenue for the quarter came in at $3.38 million versus the consensus estimate of $1.74 million.

Our accomplishments to-date in 2020, including significant progress in our influenza and COVID19 vaccine programs, are the most... More